|
CRLF2–P2RY8
(HGNC:14281, HGNC:15524)
|
acute lymphoblastic leukemia
(MONDO_0004967)
|
strong |
strong |
strong |
strong |
moderate |
|
|
NSD1–NUP98
(HGNC:14234, HGNC:8068)
|
MONDO:0004996
(MONDO:0004996)
|
strong |
strong |
strong |
strong |
moderate |
|
|
ARHGEF12–KMT2A
(HGNC:14193, HGNC:7132)
|
MONDO:0018874
(MONDO:0018874)
|
strong |
weak |
moderate |
moderate |
weak |
|
|
MGA–NUTM1
(HGNC:14010, HGNC:29919)
|
nut midline carcinoma
(MONDO_0005563)
|
strong |
weak |
moderate |
strong |
weak |
|
|
PRDM16–MECOM
(HGNC:14000, HGNC:3498)
|
MONDO:0018874
(MONDO:0018874)
|
moderate |
weak |
moderate |
moderate |
weak |
|
|
CPSF6–RARG
(HGNC:13871, HGNC:9866)
|
MONDO:0018874
(MONDO:0018874)
|
strong |
strong |
moderate |
strong |
weak |
|
|
MXD4–NUTM1
(HGNC:13906, HGNC:29919)
|
nut midline carcinoma
(MONDO_0005563)
|
moderate |
weak |
moderate |
strong |
weak |
|
|
MAML1–NR1D1
(HGNC:13632, HGNC:7962)
|
soft tissue neoplasm
(MONDO_0006424)
|
moderate |
weak |
weak |
strong |
weak |
|
|
TRAF3IP2–FYN
(HGNC:1343, HGNC:4037)
|
MONDO:0004977
(MONDO:0004977)
|
strong |
strong |
moderate |
strong |
weak |
|
|
BCL11A–IGH
(HGNC:13221, HGNC:5477)
|
MONDO:0000432
(MONDO:0000432)
|
moderate |
weak |
moderate |
strong |
weak |
|
|
BCL11B–TLX3
(HGNC:13222, HGNC:13532)
|
MONDO:0004963
(MONDO:0004963)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
BRD4–LEUTX
(HGNC:13575, HGNC:31953)
|
MONDO:0004540
(MONDO:0004540)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
BRD4–NUTM1
(HGNC:13575, HGNC:29919)
|
nut midline carcinoma
(MONDO_0005563)
|
strong |
moderate |
strong |
strong |
weak |
|
|
BRD4–NUTM2A
(HGNC:13575, HGNC:23438)
|
nut midline carcinoma
(MONDO_0005563)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
PATZ1–EWSR1
(HGNC:13071, HGNC:3508)
|
MONDO:0958300
(MONDO:0958300)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
EML4–NPM1
(HGNC:1316, HGNC:7910)
|
|
weak |
weak |
weak |
weak |
weak |
|
|
EML4–KIF5B
(HGNC:1316, HGNC:6324)
|
|
weak |
weak |
weak |
weak |
weak |
|
|
EML4–MET
(HGNC:1316, HGNC:7029)
|
lung cancer
(MONDO_0008903)
|
strong |
strong |
moderate |
strong |
weak |
|
|
KAT6A–NCOA2
(HGNC:13013, HGNC:7669)
|
acute biphenotypic leukemia
(MONDO_0020322)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
KAT6A–OPN1LW
(HGNC:13013, HGNC:9936)
|
MONDO:0020076
(MONDO:0020076)
|
weak |
weak |
weak |
weak |
weak |
|